Predictors of depression relapse and recurrence after cognitive behavioural therapy: a systematic review and meta-analysis
Abstract
Background: Cognitive behavioural therapy (CBT) is an effective psychological treatment for major depressive disorder, although some patients experience a return of symptoms after finishing therapy. The ability to predict which individuals are more vulnerable to deterioration would allow for targeted interventions to prevent short-term relapse and longer-term recurrence. Aim: This systematic review and meta-analysis aimed to identify factors associated with an increased risk of relapse and/or recurrence (RR) after CBT for depression. Method: We reviewed 13 relevant papers, of which a small set of unique samples were eligible for meta-analysis (k= 5,N= 369). Twenty-six predictor variables were identified and grouped into seven categories: residual depressive symptoms; prior episodes of depression; cognitive reactivity; stressful life events; personality factors; clinical and diagnostic factors; demographics. Results: Meta-analyses indicated that residual depressive symptoms (r= 0.34 [0.10, 0.54],p= .01) and prior episodes (r= 0.19 [0.07, 0.30],p= .002) were statistically significant predictors of RR, but cognitive reactivity was not (r= 0.18 [−0.02, 0.36],p= .08). Other variables lacked replicated findings. On average, 33.4% of patients experienced RR after CBT. Conclusions: Patients with the above risk factors could be offered evidence-based continuation-phase interventions to enhance the longer-term effectiveness of CBT.
Verified 2026-10-10 · 2 references not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and meta-analysis found that residual depressive symptoms and prior episodes of depression significantly predicted relapse and/or recurrence (RR) after acute-phase CBT, whereas cognitive reactivity did not. On average, 33.4% of patients experienced RR after CBT.
Key findings
- In random-effects meta-analyses, residual depressive symptoms were a moderate predictor of RR (r = 0.34 [0.10, 0.54], p = .01) and prior episodes were a small predictor (r = 0.19 [0.07, 0.30], p = .002); cognitive reactivity was not statistically significant (r = 0.18 [−0.02, 0.36], p = .08).
- Reported RR rates ranged from 18.5% to 46.5% after acute-phase CBT, with an average of 33.4% events within a maximum follow-up of 36 months; CBT-alone studies had a mean RR rate of 29.1%, and studies grouping treatments had a mean of 28.6%.
- Other predictors were mostly single-study findings: childhood maltreatment (OR = 2.89), dependent chronic stressors (OR = 1.34), severe independent life event post-treatment (OR = 1.03), intake anxiety (OR = 1.08), subclinical psychotic experiences (OR = 3.85), and subthreshold bipolar symptoms (OR = 1.16).
- Heterogeneity was high for residual depressive symptoms (I² = 85.3%) but not for prior episodes (I² = 0.0%); fail-safe N values were 72 for residual symptoms, 9 for prior episodes, and 7 for cognitive reactivity.
Methods
- Systematic review and random-effects meta-analysis; protocol registered in PROSPERO. Searches of Web of Science, PubMed, PsycINFO, and Scopus (January 1990–March 2017) returned 275 unique titles/abstracts; 59 full texts were assessed, and 13 articles were included (9 RCTs, 4 longitudinal cohort studies; total pooled sample N = 1219).
- Eligible studies included adults with unipolar major depressive disorder who completed acute-phase CBT without continuation-phase interventions, were published in peer-reviewed English-language journals, had follow-up of at least 6 months, and investigated predictors of RR.
- Meta-analysis was restricted to predictors examined in two or more studies with sufficient statistics; inferential statistics were converted to correlation coefficients (r), with heterogeneity assessed using Q and I², publication bias examined via funnel plot asymmetry tests, and fail-safe N calculated. The meta-analysis included k = 5, N = 369.
Limitations
- The paper states that at least half of the reviewed studies used arbitrary or unconventional operational definitions of relapse, making it impossible to clearly disentangle predictors of relapse versus recurrence.
- The paper states that most primary studies were underpowered: the largest number of RR events was 40 and the mean was 19, whereas detecting a medium effect would require 212 participants (64 RR cases) and a small effect 1310 participants (393 RR cases); over half of studies only reported significant results, suggesting possible selective reporting.
- The paper states that exclusions of grey literature, non-English publications, children and young people, and continuation-phase studies limit the review, and the small number of included studies precluded subgroup and moderator analyses; evident from the text, the meta-analyses rested on only five studies and high heterogeneity was present for residual depressive symptoms.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 40 cited sources checked · 0 supported · 0 flagged
- Findingown data§ Study characteristics · p. 6
No single or consistent cut-off was used across studies to demarcate relapse and recurrence events.
“An important discrepancy is that no single or consistent cut-off was used across studies to demarcate relapse and recurrence events.”
Quote in the paperSubstantial claim - Findingown data§ Study characteristics · p. 6
There was no significant association between relapse/recurrence rates and follow-up duration (r = 0.46, p = 0.16).
“However, after conducting a Pearson ' s correlation between RR rates and follow-up duration, we found no significant association ( r = 0.46, p = 0.16).”
Quote in the paperNot a substantial claim - Findingown data§ Study characteristics · p. 6
The cut-off period to define relapse events varied from 4 up to 24 months across different studies.
“As shown in Table 1, the cut-off period (from the time of remission of symptoms) to define ' relapse ' events varied from 4 up to 24 months across different studies, thus blurring the boundaries between these clinical phenomena.”
Quote in the paperSubstantial claim - Findingown data§ Cognitive reactivity · p. 9
Cognitive reactivity is not a statistically significant predictor of relapse/recurrence after CBT (r = 0.18, 95% CI −0.02-0.36, p = .08).
“The pooled effect was not statistically significant; r = 0.18 ( -0.02, 0.36), p = .08.”
Quote in the paperNot a substantial claim - Findingown data§ Residual depressive symptoms · p. 9
Residual depressive symptoms are a statistically significant predictor of relapse/recurrence after CBT, with a moderate pooled correlation (r = 0.34, 95% CI 0.10-0.54, p = .01).
“The pooled effect was statistically significant, denoting a moderate correlation between residual depressive symptoms and RR; r = 0.34 (95% CI 0.10, 0.54), p = .01.”
Quote in the paperSubstantial claim
- Findingown data§ Prior episodes of depression · p. 9
Prior depression episodes are a statistically significant predictor of relapse/recurrence after CBT, with a small pooled correlation (r = 0.19, 95% CI 0.07-0.30, p = .002).
“The pooled effect was statistically significant, denoting a small correlation between prior depression episodes and RR; r = 0.19 (0.07, 0.30), p = .002.”
Quote in the paperSubstantial claim - Findingown data§ Rates of RR · p. 8
On average, 33.4% of patients experienced relapse/recurrence after CBT within a maximum follow-up period of 36 months.
“There was an average of 33.4% events within a maximum follow-up period of 36 months.”
Quote in the paperSubstantial claim - Findingown data§ Rates of RR · p. 8
The reported rates of depressive relapse/recurrence varied between studies, ranging from 18.5 to 46.5% after acute-phase CBT.
“The reported rates of depressive RR varied between studies, ranging from 18.5 to 46.5% after acute-phase CBT.”
Quote in the paperNot a substantial claim - Findingown data§ Predictors of RR · p. 8
Only four variables were consistently assessed as potential predictors of relapse/recurrence in more than one study: residual depressive symptoms, prior episodes, cognitive reactivity, and marital status.
“Only four variables were consistently assessed as potential predictors of RR in more than one study (residual depressive symptoms, prior episodes, cognitive reactivity, marital status).”
Quote in the paperSubstantial claim - Findingreasoning§ Discussion · p. 12
The lack of replication was particularly the case for most personality factors, demographics, stressful life events, and clinical and diagnostic factors.
“This was particularly the case for most personality factors, demographics, stressful life events, and clinical and diagnostic factors.”
Quote in the paperSubstantial claim - Findingown data§ Limitations · p. 12
At least half of the reviewed studies applied arbitrary or unconventional operational definitions of relapse.
“As shown in Table 1, at least half of the reviewed studies applied arbitrary or unconventional operational definitions of relapse, which made it impossible to clearly disentangle predictors of relapse versus recurrence events.”
Quote in the paperSubstantial claim - Findingown data§ Discussion · p. 12
There was no evidence of significant heterogeneity in the sample of included studies for cognitive reactivity.
“Our meta-analysis does not support this assertion, as the pooled correlation between cognitive reactivity and RR was not significant, and there was no evidence of significant heterogeneity in the sample of included studies.”
Quote in the paperSubstantial claim - Findingown data§ Discussion · p. 12
There was no evidence of potential publication bias in the meta-analyses of residual depressive symptoms and prior episodes as predictors of relapse/recurrence.
“Furthermore, we found no evidence of potential publication bias, and the failsafe N calculations for each of these predictors (72 and 9) indicated that numerous studies with null findings would be needed to overturn these results.”
Quote in the paperNot a substantial claim - Findingown data§ Discussion · p. 12
Prior episodes have a statistically significant moderate correlation with risk of relapse/recurrence after CBT for depression (r = 0.19).
“Our meta-analytic results indicated statistically significant and moderate correlations ( r = 0.34 and r = 0.19) between each of these variables and the risk of RR.”
Quote in the paperSubstantial claim - Findingown data§ Discussion · p. 12
The pooled correlation between cognitive reactivity and relapse/recurrence after CBT for depression is not significant.
“Our meta-analysis does not support this assertion, as the pooled correlation between cognitive reactivity and RR was not significant, and there was no evidence of significant heterogeneity in the sample of included studies.”
Quote in the paperSubstantial claim - Findingown data§ Discussion · p. 12
Failsafe N calculations for residual depressive symptoms and prior episodes (72 and 9) indicate that numerous studies with null findings would be needed to overturn these results.
“Furthermore, we found no evidence of potential publication bias, and the failsafe N calculations for each of these predictors (72 and 9) indicated that numerous studies with null findings would be needed to overturn these results.”
Quote in the paperSubstantial claim - Findingown data§ Conclusions · p. 14
At least 30% of patients experience relapse/recurrence after acute-phase CBT for depression.
“In summary, at least 30% of patients were found to experience RR (relapse and/or recurrence) after acute-phase CBT, confirming that depression is a refractory condition, particularly for patients with prior episodes and with residual depressive symptoms at the end of treatment.”
Quote in the paperSubstantial claim - Findingnone given§ Clinical implications · p. 14
Approximately one-third of patients have a clinically significant deterioration of symptoms after CBT for depression.
“It is clear that depression is a highly refractory condition, with approximately one-third of patients having a clinically significant deterioration of symptoms after CBT.”
Quote in the paperSubstantial claim - Study design and conductown data§ Data extraction and synthesis · p. 4
The small number of studies (≤5) entered into meta-analysis precluded more detailed sub-group or moderator analyses.
“The small number of studies ( ≤ 5) entered into meta-analysis precluded more detailed sub-group or moderator analyses.”
Quote in the paperNot a substantial claim - Study design and conductreasoning§ Allocation concealment and blinding · p. 8
There is a high risk of bias towards concealment because participants and therapists would be aware of whether they were receiving CBT or pharmacotherapy.
“Due to the nature of the studies included in this review, there is a high risk of bias towards concealment as participants would be aware if they were receiving CBT or pharmacotherapy, as would the therapist(s) administering the treatment.”
Quote in the paperNot a substantial claim - Study design and conductown data§ Sequence generation · p. 6
Most of the studies did not provide sufficient information to assess whether there was a risk of bias due to randomization.
“Most of the studies did not provide sufficient information to assess whether there was a risk of bias due to randomization. Most studies lacked a detailed description of the randomization procedures.”
Quote in the paperNot a substantial claim - Study design and conductown data§ Data extraction and synthesis · p. 5
It was not possible to apply meta-analytic methods for numerous potential variables due to under-reporting of statistical information or lack of replication in multiple studies.
“It was not possible to apply meta-analytic methods for numerous potential variables due to under-reporting of statistical information or lack of replication in multiple studies.”
Quote in the paperSubstantial claim - Study design and conductown data§ Prior episodes of depression · p. 9
There was no significant evidence of heterogeneity in the meta-analysis of prior depression episodes and relapse/recurrence (Q = 2.64, df = 3, p = 0.45; I2 = 0.0%).
“There was no significant evidence of heterogeneity; Q = 2.64, d.f. = 3, p = 0.45; I 2 = 0.0% (95% CI 0.0, 82.6).”
Quote in the paperNot a substantial claim - Premisecitation§ Other clinical and diagnostic factors · p. 11
Post-treatment anxiety levels do not predict relapse/recurrence after CBT for depression (Forand and DeRubeis, 2013).
“High levels of intake anxiety (pre-treatment) on the Beck Anxiety Inventory (BAI; Beck et al. , 1988) predicted a shorter time to RR after completing treatment (OR = 1.08), but post-treatment anxiety levels did not predict RR (Forand and DeRubeis, 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Forand and DeRubeis, 2013
Not checked in the free run.
- Study design and conductown data§ Cognitive reactivity · p. 9
There was no significant evidence of heterogeneity in the meta-analysis of cognitive reactivity and relapse/recurrence (Q = 6.81, df = 3, p = 0.08; I2 = 56.0%).
“There was no significant evidence of heterogeneity; Q = 6.81, d.f. = 3, p = 0.08; I 2 = 56.0% (95% CI 0.0, 85.4).”
Quote in the paperNot a substantial claim - Premisecitation§ Other clinical and diagnostic factors · p. 11
High pre-treatment anxiety on the Beck Anxiety Inventory predicts shorter time to relapse/recurrence after completing CBT for depression (OR = 1.08) (Forand and DeRubeis, 2013).
“High levels of intake anxiety (pre-treatment) on the Beck Anxiety Inventory (BAI; Beck et al. , 1988) predicted a shorter time to RR after completing treatment (OR = 1.08), but post-treatment anxiety levels did not predict RR (Forand and DeRubeis, 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Forand and DeRubeis, 2013
Not checked in the free run.
- Study design and conductown data§ Residual depressive symptoms · p. 9
There was evidence of considerable heterogeneity in the meta-analysis of residual depressive symptoms and relapse/recurrence (Q = 27.27, df = 4, p < 0.0001; I2 = 85.3%).
“There was evidence of considerable heterogeneity; Q = 27.27, d.f. = 4, p < 0.0001; I 2 = 85.3% (95% CI 67.6, 93.4).”
Quote in the paperNot a substantial claim - Premisecitation§ Personality factors · p. 11
Greater hopelessness scores on the Hopelessness Scale significantly predicted relapse/recurrence after CBT for depression (Evans et al., 1992).
“Greater neuroticism scores on the Eysenck Personality Inventory -Neuroticism and Extroversion Scales (Eysenck, 1968) and greater scores of hopelessness on the Hopelessness Scale (Beck et al. , 1974) also significantly predicted RR (Evans et al. , 1992).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Evans et al. , 1992
Not checked in the free run.
- Premisecitation§ Personality factors · p. 11
Attributional style is not significantly associated with risk of relapse/recurrence after CBT for depression (Evans et al., 1992; Gollan et al., 2006).
“Attributional style was not found to be significantly associated with risk of RR (Evans et al. , 1992; Gollan et al. , 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Evans et al. , 1992
Not checked in the free run.
- cites Gollan et al. , 2006
Not checked in the free run.
- Premisecitation§ Other clinical and diagnostic factors · p. 11
Longer time to treatment entry is associated with longer time to relapse/recurrence after CBT for depression (Quiring et al., 2002).
“Quiring et al. (2002) found that as time to treatment entry (time between the onset of depressive symptoms and the time when treatment begins) increased, time taken to RR also significantly increased.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Quiring et al. (2002)
Not checked in the free run.
- Study design and conductown data§ Residual depressive symptoms · p. 9
According to the fail-safe N, 72 null studies would be needed to overturn the meta-analytic result for residual depressive symptoms.
“According to the fail-safe N, 72 null studies would be needed to overturn this meta-analytic result.”
Quote in the paperNot a substantial claim - Study design and conductown data§ Residual depressive symptoms · p. 9
Tests for funnel plot asymmetry were not statistically significant, indicating no evidence of likely publication bias for the residual depressive symptoms meta-analysis.
“The regression ( t = 0.4729, d.f. = 3, p = 0.67) and rank correlation tests (Kendall ' s tau = 0.2000, p = 0.82) for funnel plot asymmetry were not statistically significant, indicating no evidence of likely publication bias.”
Quote in the paperNot a substantial claim - Premisecitation§ Personality factors · p. 11
Greater neuroticism scores on the Eysenck Personality Inventory-Neuroticism and Extroversion Scales significantly predicted relapse/recurrence after CBT for depression (Evans et al., 1992).
“Greater neuroticism scores on the Eysenck Personality Inventory -Neuroticism and Extroversion Scales (Eysenck, 1968) and greater scores of hopelessness on the Hopelessness Scale (Beck et al. , 1974) also significantly predicted RR (Evans et al. , 1992).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Evans et al. , 1992
Not checked in the free run.
- Premisecitation§ Personality factors · p. 11
Low perceived pleasure post-treatment on the Pleasant Events Schedule predicted relapse/recurrence after CBT for depression (Gollan et al., 2006).
“A dependent personality style on the Millon Clinical Multiaxial Inventory-II (Millon, 1987) and scoring low on the Pleasant Events Schedule (PES) (MacPhillamy and Lewisohm, 1982) representing low perceived pleasure post-treatment also predicted RR (Gollan et al. , 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gollan et al. , 2006
Not checked in the free run.
- Premisecitation§ Other clinical and diagnostic factors · p. 11
Slower decrease in symptom scores (longer time to treatment response) predicts higher chance of relapse/recurrence after CBT for depression (Thase et al., 1992).
“A slower decrease in symptom scores (i.e. a longer time to treatment response) also significantly predicted a higher chance of RR (Thase et al. , 1992).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Thase et al. , 1992 source
Not checked in the free run.
- Premisecitation§ Personality factors · p. 11
A dependent personality style on the Millon Clinical Multiaxial Inventory-II predicted relapse/recurrence after CBT for depression (Gollan et al., 2006).
“A dependent personality style on the Millon Clinical Multiaxial Inventory-II (Millon, 1987) and scoring low on the Pleasant Events Schedule (PES) (MacPhillamy and Lewisohm, 1982) representing low perceived pleasure post-treatment also predicted RR (Gollan et al. , 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gollan et al. , 2006
Not checked in the free run.
- Premisecitation§ Other clinical and diagnostic factors · p. 11
Abnormal sleep patterns are not significant predictors of relapse/recurrence after CBT for depression (Thase et al., 1996).
“Non-significant diagnostic and clinical history features included: age at onset of disorder; duration of current episode; insidiousness of onset; presence of precipitant; previous treatment with tricyclics; history of hospitalization; suicidal ideation; history of suicide attempts; history of alcoholism; history of substance abuse; Research Diagnostic Criteria (RDC) depressive sub-type; double dep”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Thase et al. , 1996
Not checked in the free run.
- Premisecitation§ Discussion · p. 12
Residual depressive symptoms and prior episodes are the most robust predictors of depressive relapse/recurrence (Burcusa and Iacono, 2007; Keller et al., 1983; Kessing et al., 2004; Mueller et al., 1999).
“Residual depressive symptoms and prior episodes have been previously cited as the most robust predictors of depressive RR (Burcusa and Iacono, 2007; Keller et al. , 1983; Kessing et al. , 2004; Mueller et al. , 1999).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Burcusa and Iacono, 2007
Not checked in the free run.
- cites Keller et al. , 1983
Not checked in the free run.
- cites Kessing et al. , 2004
Not checked in the free run.
- Premisecitation§ Other clinical and diagnostic factors · p. 11
Post-treatment cortisol levels interact with number of prior episodes in predicting relapse/recurrence after CBT for depression (Chopra et al., 2008).
“Chopra et al. (2008) found that levels of cortisol post-treatment interacted with patients ' number of prior episodes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chopra et al. (2008)
Not checked in the free run.
- Interpretationown data§ Limitations · p. 12
The arbitrary or unconventional operational definitions of relapse made it impossible to clearly disentangle predictors of relapse versus recurrence events.
“As shown in Table 1, at least half of the reviewed studies applied arbitrary or unconventional operational definitions of relapse, which made it impossible to clearly disentangle predictors of relapse versus recurrence events.”
Quote in the paperSubstantial claim - Premisecitation§ Other clinical and diagnostic factors · p. 11
Sub-clinical psychotic experiences on the Community Assessment of Psychic Experiences predict higher risk of relapse/recurrence after CBT for depression (OR = 3.85) (Wigman et al., 2014).
“Participants that presented symptoms of a sub-clinical psychotic experience measured by the Community Assessment of Psychic Experiences (CAPE; Brenner et al. , 2007) and sub-threshold bipolar symptoms measured on the Mood Disorders Questionnaire (MDQ) (Hirschfeld et al. , 2000) were also found to be significantly more prone to RR with odds ratios of 3.85 and 1.16, respectively (Wigman et al. , 201”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wigman et al. , 2014
Not checked in the free run.
- Premisecitation§ Other clinical and diagnostic factors · p. 11
Sub-threshold bipolar symptoms on the Mood Disorders Questionnaire predict higher risk of relapse/recurrence after CBT for depression (OR = 1.16) (Wigman et al., 2014).
“Participants that presented symptoms of a sub-clinical psychotic experience measured by the Community Assessment of Psychic Experiences (CAPE; Brenner et al. , 2007) and sub-threshold bipolar symptoms measured on the Mood Disorders Questionnaire (MDQ) (Hirschfeld et al. , 2000) were also found to be significantly more prone to RR with odds ratios of 3.85 and 1.16, respectively (Wigman et al. , 201”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wigman et al. , 2014
Not checked in the free run.
- Premisecitation§ Discussion · p. 12
Mood reactivity may be more relevant than cognitive reactivity in the prediction of relapse/recurrence after CBT for depression (Lethbridge and Allen, 2008; Rucci et al., 2011; van Rijsbergen et al., 2013).
“This fits with emerging studies that suggest that mood reactivity may be more relevant than cognitive reactivity in the prediction of RR (Lethbridge and Allen, 2008; Rucci et al. , 2011; van Rijsbergen et al. , 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Lethbridge and Allen, 2008
Not checked in the free run.
- cites Rucci et al. , 2011
Not checked in the free run.
- cites van Rijsbergen et al. , 2013
Not checked in the free run.
- Premisecitation§ Demographics · p. 11
Marital status is not a significant predictor of relapse/recurrence after CBT for depression (Evans et al., 1992).
“Thase et al. (1992) found that unmarried participants were more likely to experience RR; however, Evans et al. (1992) did not find marital status to be a significant predictor.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Evans et al. (1992)
Not checked in the free run.
- Premisecitation§ Other clinical and diagnostic factors · p. 11
Among patients with high post-treatment cortisol levels, rates of relapse/recurrence are similar regardless of number of prior episodes (Chopra et al., 2008).
“Patients with high cortisol levels had similar rates of RR regardless of prior episodes, but patients with low cortisol levels with two or fewer prior episodes tended to have lower rates of RR.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chopra et al. (2008)
Not checked in the free run.
- Premisecitation§ Limitations · p. 12
According to Cohen's criteria, detecting a large effect size with 80% power in a simple comparison of means requires at least 26 relapse/recurrence cases (overall sample 85 assuming 30% relapse/recurrence base rate).
“For example, according to Cohen ' s sample size estimation criteria (Cohen, 1992), a simple comparison of means (between cases that RR and those who do not) in a continuous predictor using ANOVA would require at least 26 RR cases to detect a large effect size with 80% power, and thus an overall sample of 85 if we assume a RR base rate of 30%.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cohen, 1992
Not checked in the free run.
- Interpretationreasoning§ Limitations · p. 12
The small sample sizes across most reviewed studies mean they were highly likely to be underpowered to detect significant factors with small to moderate effects on risk of relapse/recurrence.
“The small sample sizes across most of these studies means that they were highly likely to be underpowered to detect significant factors that may have a small to moderate effect on the risk of RR.”
Quote in the paperSubstantial claim - Premisecitation§ Other clinical and diagnostic factors · p. 11
Among patients with low post-treatment cortisol levels, those with two or fewer prior episodes tend to have lower rates of relapse/recurrence (Chopra et al., 2008).
“Patients with high cortisol levels had similar rates of RR regardless of prior episodes, but patients with low cortisol levels with two or fewer prior episodes tended to have lower rates of RR.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chopra et al. (2008)
Not checked in the free run.
- Interpretationreasoning§ Clinical implications · p. 14
Depression is a highly refractory condition.
“It is clear that depression is a highly refractory condition, with approximately one-third of patients having a clinically significant deterioration of symptoms after CBT.”
Quote in the paperNot a substantial claim - Study design and conductown data§ Limitations · p. 13
The small number of included studies did not allow further sub-group and moderator analyses.
“Furthermore, the small number of included studies did not allow further sub-group and moderator analyses.”
Quote in the paperNot a substantial claim - Premisecitation§ Clinical implications · p. 14
The majority (78%) of clinically significant deterioration events occur within the first 6 months after therapy (Delgadillo et al., 2018).
“Studies using monthly post-treatment tracking of symptoms show that the majority (78%) of clinically significant deterioration events occur within the first 6 months after therapy, so this is a critical period to monitor response to psychological care (Delgadillo et al. , 2018).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Delgadillo et al. , 2018
Not checked in the free run.
- Interpretationown data§ Limitations · p. 12
The selective reporting of only significant results potentially indicates increased risk of selective reporting.
“This potentially indicates increased risk of selective reporting.”
Quote in the paperNot a substantial claim - Premisecitation§ Limitations · p. 12
Detecting a small effect size requires 1310 participants (393 relapse/recurrence cases).
“Using these criteria, 212 participants (64 RR cases) would be necessary to detect a medium effect size and 1310 participants (393 RR cases) to detect a small effect size.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cohen, 1992
Not checked in the free run.
- Premisecitation§ Limitations · p. 12
Detecting a medium effect size requires 212 participants (64 relapse/recurrence cases).
“Using these criteria, 212 participants (64 RR cases) would be necessary to detect a medium effect size and 1310 participants (393 RR cases) to detect a small effect size.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cohen, 1992
Not checked in the free run.
- Premisecitation§ Clinical implications · p. 14
People who experience relapse/recurrence are often more severely impaired with each subsequent episode (Scott et al., 2003).
“As others have argued (Scott et al. , 2003), adjunctive and continuation-phase interventions are costly, but gains in prevention tend to outweigh the costs of future episodes of care for people that experience RR, who are often more severely impaired with each subsequent episode.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott et al. , 2003
Not checked in the free run.
- Interpretationcitation§ Clinical implications · p. 14
The first 6 months after therapy is a critical period to monitor response to psychological care.
“Studies using monthly post-treatment tracking of symptoms show that the majority (78%) of clinically significant deterioration events occur within the first 6 months after therapy, so this is a critical period to monitor response to psychological care (Delgadillo et al. , 2018).”
Quote in the paperSubstantial claim - Interpretationreasoning§ Limitations · p. 12
Not even the largest reviewed study was sufficiently powered to detect a medium effect size.
“We therefore conclude that not even the largest of these studies was sufficiently powered to detect a medium effect size, and the fact that many studies analysed multiple variables further reduces our confidence in their suitability to reliably detect significant predictors of RR.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Limitations · p. 12
The fact that many studies analysed multiple variables further reduces confidence in their suitability to reliably detect significant predictors of relapse/recurrence.
“We therefore conclude that not even the largest of these studies was sufficiently powered to detect a medium effect size, and the fact that many studies analysed multiple variables further reduces our confidence in their suitability to reliably detect significant predictors of RR.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 20
- The quote only partly states this claim. 4
- May combine two claims. 18
Classified as probably not a substantial claim.
Findingown data§ Selection of articles · p. 4Thirteen articles were identified as eligible for inclusion in the review.
“Thirteen articles were identified as eligible for inclusion in the review.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown data§ Discussion · p. 12Residual depressive symptoms have a statistically significant moderate correlation with risk of relapse/recurrence after CBT for depression (r = 0.34).
“Our meta-analytic results indicated statistically significant and moderate correlations ( r = 0.34 and r = 0.19) between each of these variables and the risk of RR.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Discussion · p. 12The majority of significant predictors of relapse/recurrence after CBT for depression were tested in only single studies and lacked replicated findings.
“Several significant predictors were identified across studies; however, the majority were only tested in single studies and lacked replicated findings.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Discussion · p. 12Heterogeneity was high for residual depressive symptoms (I2 = 85.3%) but not for prior episodes (I2 = 0%) in the meta-analyses.
“Indices of heterogeneity were high (I 2 = 85.3%) for residual depressive symptoms but not for prior episodes (I 2 = 0%).”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Findingown data§ Discussion · p. 12Three variables (residual depressive symptoms, prior episodes, cognitive reactivity) were examined across multiple studies with sufficient data for meta-analysis.
“Three variables, however, were examined across multiple studies that reported sufficient data to enable meta-analysis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone given§ Future research · p. 13Many studies deemed ineligible for this review were well-designed controlled trials with adequate longitudinal follow-up periods but did not quantify relapse/recurrence events or rates at follow-up.
“Many studies that were deemed ineligible for this review were well-designed controlled trials with adequate longitudinal follow-up periods; however, these did not quantify RR events or rates at follow-up.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Limitations · p. 12Over half of the reviewed studies only reported significant results, with no mention of non-significant predictors in most studies.
“Furthermore, over half of the reviewed studies only reported significant results -there was no mention of variables that were non-significant predictors of RR in most of the studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ Future research · p. 13Personality factors (e.g., neuroticism, hopelessness, perceived pleasure) predicted relapse/recurrence most frequently in the included studies, albeit in single studies.
“Personality factors (e.g. neuroticism, hopelessness, perceived pleasure) predicted RR most frequently in the included studies, albeit in single studies.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingcitation§ Limitations · p. 12The largest number of subjects experiencing a relapse/recurrence event in the reviewed studies was 40, and the mean was 19.
“The largest number of subjects that experienced a RR event in the reviewed studies was 40 (Gollan et al. , 2006), whilst the mean was only 19.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Study protocol · p. 4The systematic review protocol was registered and published in PROSPERO ahead of conducting the review.
“The systematic review protocol was registered and published in the International Prospective Register of Systematic Reviews (PROSPERO) ahead of conducting the review (protocol ID: PROSPERO 2017:CRD42017057747).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown data§ Selection of articles · p. 4Fifty-nine full-text articles were assessed for eligibility independently by two reviewers, with disagreements resolved by consensus.
“Fifty-nine full-text articles were then assessed for eligibility independently by two reviewers; any disagreements were discussed and resolved by consensus.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ Introduction · p. 3Some patients are prone to relapse/recurrence after CBT, with rates between studies ranging from 10 to 49%.
“However, some patients are prone to RR after CBT as described in a review by Paykel (2007), where rates between studies ranged from 10 to 49%.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Paykel (2007)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Quality assessment · p. 4There were no disagreements in risk-of-bias results between the two independent reviewers.
“There were no disagreements in results between the two independent reviewers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Data extraction and synthesis · p. 4Two reviewers extracted the data independently.
“Two reviewers extracted the data independently.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ Introduction · p. 3CBT is an effective psychological treatment for major depressive disorder.
“Cognitive behavioural therapy (CBT) is an increasingly available and effective psychological intervention, recommended as a first-line treatment in clinical guidelines for the management of depression (American Psychiatric Association, 2000b; National Institute for Health and Care Excellence, 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites American Psychiatric Association, 2000b
Not checked in the free run.
- cites National Institute for Health and Care Excellence, 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown data§ Prior episodes of depression · p. 9Tests for funnel plot asymmetry were not statistically significant and the fail-safe N was 9 for the prior depression episodes meta-analysis.
“The regression ( t = -0.8810, d.f. = 2, p = 0.47) and rank correlation tests (Kendall ' s tau = -0.33, p = 0.75) for funnel plot asymmetry were not statistically significant and the fail-safe N was 9.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown data§ Cognitive reactivity · p. 9Tests for funnel plot asymmetry were not statistically significant and the fail-safe N was 7 for the cognitive reactivity meta-analysis.
“The regression ( t = 1.40, d.f. = 2, p = 0.30) and rank correlation tests (Kendall ' s tau = 0.33, p = 0.75) for funnel plot asymmetry were not statistically significant and the fail-safe N was 7.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone given§ Other sources of bias · p. 8In Evans et al. (1992) and Forand and DeRubeis (2013), the authors of the paper were also the therapists, potentially leading to researcher allegiance effects.
“In Evans et al. (1992) and Forand and DeRubeis (2013), the authors of the paper are also the therapists within the study, potentially leading to researcher allegiance effects.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Evans et al., 1992
Not checked in the free run.
- cites Forand and DeRubeis, 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Incomplete outcome data · p. 8There were high rates of attrition in the included longitudinal studies.
“As is common in longitudinal studies, there were high rates of attrition.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ Demographics · p. 11Age, gender, race, employment status, education, socioeconomic status, and intelligence are not associated with relapse/recurrence after CBT for depression (Evans et al., 1992).
“Other demographic characteristics that were not associated with RR included age, gender, race, employment status, education, socioeconomic status, and intelligence (Evans et al. , 1992).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Evans et al. , 1992
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Premisecitation§ Demographics · p. 11Unmarried participants are more likely to experience relapse/recurrence after CBT for depression (Thase et al., 1992).
“Thase et al. (1992) found that unmarried participants were more likely to experience RR; however, Evans et al. (1992) did not find marital status to be a significant predictor.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Thase et al. (1992) source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.
Premisecitation§ Other clinical and diagnostic factors · p. 11A range of diagnostic and clinical history features (age at onset, duration of current episode, insidiousness of onset, presence of precipitant, previous treatment with tricyclics, history of hospitalization, suicidal ideation, history of suicide attempts, history of alcoholism, history of substance abuse, RDC depressive sub-type, double depression, family history of depression, general level of功能
“Non-significant diagnostic and clinical history features included: age at onset of disorder; duration of current episode; insidiousness of onset; presence of precipitant; previous treatment with tricyclics; history of hospitalization; suicidal ideation; history of suicide attempts; history of alcoholism; history of substance abuse; Research Diagnostic Criteria (RDC) depressive sub-type; double dep”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Evans et al. , 1992
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ Discussion · p. 12Cognitive reactivity as measured by the DAS following a mood induction procedure is a commonly cited predictor of depressive relapse/recurrence (Segal et al., 1999, 2006).
“A third commonly cited predictor of depressive RR is cognitive reactivity as measured by the DAS following a mood induction procedure (Segal et al. , 1999, 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Segal et al. , 1999, 2006
Not checked in the free run.
May combine two claims.
Interpretationown data§ Conclusions · p. 14Depression is a refractory condition, particularly for patients with prior episodes and with residual depressive symptoms at the end of treatment.
“In summary, at least 30% of patients were found to experience RR (relapse and/or recurrence) after acute-phase CBT, confirming that depression is a refractory condition, particularly for patients with prior episodes and with residual depressive symptoms at the end of treatment.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown data§ Limitations · p. 13The present review conducted quantitative meta-analyses of available data.
“The present review had several strengths including the pre-registration of the study protocol; searches across multiple databases, reference lists and direct requisition to corresponding authors; double rating of included studies; and quantitative meta-analyses of available data.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ Clinical implications · p. 14Adjunctive and continuation-phase interventions are costly, but gains in prevention tend to outweigh the costs of future episodes of care for people who experience relapse/recurrence (Scott et al., 2003).
“As others have argued (Scott et al. , 2003), adjunctive and continuation-phase interventions are costly, but gains in prevention tend to outweigh the costs of future episodes of care for people that experience RR, who are often more severely impaired with each subsequent episode.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott et al. , 2003
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Limitations · p. 13The present review used double rating of included studies.
“The present review had several strengths including the pre-registration of the study protocol; searches across multiple databases, reference lists and direct requisition to corresponding authors; double rating of included studies; and quantitative meta-analyses of available data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Limitations · p. 13The present review had a pre-registered study protocol.
“The present review had several strengths including the pre-registration of the study protocol; searches across multiple databases, reference lists and direct requisition to corresponding authors; double rating of included studies; and quantitative meta-analyses of available data.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ Clinical implications · p. 14Continuation-phase CBT and MBCT are well-established relapse prevention interventions for depression (Vittengl et al., 2007; Piet and Hougaard, 2011).
“There are also well-established relapse prevention interventions that should be offered after patients have completed an acute-phase treatment, such as continuation-phase CBT (Vittengl et al. , 2007) and MBCT (Piet and Hougaard, 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Vittengl et al. , 2007
Not checked in the free run.
- cites Piet and Hougaard, 2011
Not checked in the free run.
May combine two claims.
Study design and conductnone given§ Limitations · p. 13The present review excluded grey literature, publications in languages other than English, studies in children and young people, and studies including a continuation-phase procedure or intervention.
“However, this review was limited by the exclusions imposed on grey literature, publications in languages other than English, studies in children and young people, and studies which included a continuation-phase procedure or intervention.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone given§ Limitations · p. 13The present review searched multiple databases, reference lists, and directly requisitioned corresponding authors.
“The present review had several strengths including the pre-registration of the study protocol; searches across multiple databases, reference lists and direct requisition to corresponding authors; double rating of included studies; and quantitative meta-analyses of available data.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
No prior systematic review and quantitative synthesis of predictors of relapse/recurrence after CBT for depression exists.
“This study presents the first systematic review and quantitative synthesis of the literature on predictors of RR (relapse and/or recurrence) after CBT for depression.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This finding is consistent with other studies where few clinical factors predicted relapse in patients after treatment for MDD.
“This is consistent with other studies where few clinical factors predicted relapse in patients after treatment for MDD.15,20–23”
After treatment, a higher risk of relapse has been associated with the number and severity of previous episodes, the persistence of residual symptoms, and a history of childhood maltreatment.
“after treatment, a higher risk of relapse has been associated with the number and severity of previous episodes, the persistence of residual symptoms and a history of childhood maltreatment.9,15,19–23”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
A fifth predictor was assessed in multiple studies
MinorThe paper says only four variables were assessed as predictors in more than one study, but it also reports that attributional style was assessed in two studies.
“Only four variables were consistently assessed as potential predictors of RR in more than one study (residual depressive symptoms, prior episodes, cognitive reactivity, marital status).”
“Attributional style was not found to be significantly associated with risk of RR (Evans et al. , 1992; Gollan et al. , 2006).”
Reported minimum RR rate exceeds a rate in Table 1
MinorThe stated range begins at 18.5%, whereas Table 1 reports 2/22 (9%) for the CBT subjects in Harkness et al. (2014).
“The reported rates of depressive RR varied between studies, ranging from 18.5 to 46.5% after acute-phase CBT.”
“Harkness et al. (2014) | 108 | Both | < 4 m of remission | 2/22(9)”
Conflicting counts of predictor variables
MinorThe abstract says 26 predictor variables were identified, but the results say the included studies investigated 62 variables as potential predictors.
“Twenty-six predictor variables were identified and grouped into seven categories: residual depressive symptoms; prior episodes of depression; cognitive reactivity; stressful life events; personality factors; clinical and diagnostic factors; demographics.”
“Studies included in this review investigated 62 variables as potential predictors of relapse.”
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · see citing works
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859 · see citing works
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · see citing works
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 4× · see citing works
“Five studies examined residual depressive symptoms (e.g. measured using the Beck Depression Inventory; Beck et al., 1961, or Hamilton Rating Scale for Depression; Hamilton, 1960) at the end of the acute phase of treatment as a predictor of RR.”
MethodInfluentialCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · see citing works
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225 · see citing works
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799 · see citing works
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771 · see citing works
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269 · see citing works
The measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494 · see citing works
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,228 · see citing works
Breslow, N. E., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,382 · see citing works
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236 · see citing works
A Fail-Safe N for Effect Size in Meta-Analysis
Orwin, R. G. (1983) · Journal of Educational Statistics · doi:10.2307/1164923 · Cited by 2,064 · see citing works
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1× · see citing works
“Some have defined recovery as the full remission of symptoms for a period of 4 months (Rush et al., 2006), but others propose 6 months (Frank et al., 1991) or even 12 months (Reimherr et al., 1998).”
BackgroundHirschfeld, R. M. A., Williams, J. B. W., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1873 · Cited by 1,525 · see citing works
How Many Studies Do You Need?: A Primer on Statistical Power for Meta-Analysis
Valentine, J. C., Pigott, T. D., & Rothstein, H. R. (2010) · Journal of Educational and Behavioral Statistics · doi:10.3102/1076998609346961 · Cited by 1,294 · see citing works
Millon Clinical Multiaxial Inventory manual
Millon, T. (1983) · Medical Entomology and Zoology · Cited by 1,236 · see citing works
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800702 · Cited by 1,066 · see citing works
Risk for recurrence in depression
Burcusa, S. L., & Iacono, W. G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.02.005 · Cited by 1,023 · see citing works
Distributed Disturbances in Brain Structure and Function in Schizophrenia
Lewis, D. A. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 971 · see citing works
Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
Mueller, T. I., Leon, A. C., Keller, M. B., Solomon, D. A., Endicott, J., Coryell, W., Warshaw, M., & Maser, J. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1000 · Cited by 897 · see citing works
Piet, J., & Hougaard, E. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.05.002 · Cited by 807 · see citing works
Prevention of Relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.417 · Cited by 735 · see citing works
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707 · see citing works
Monroe, S. M., & Harkness, K. L. (2005) · Psychological Review · doi:10.1037/0033-295x.112.2.417 · Cited by 693 · see citing works
Childhood Experience of Care and Abuse (CECA): A Retrospective Interview Measure
Bifulco, A., Brown, G. W., & Harris, T. O. (1994) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1994.tb01284.x · Cited by 579 · see citing works
Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.475 · Cited by 551 · see citing works
Differential Relapse Following Cognitive Therapy and Pharmacotherapy for Depression
Evans, M. D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100046009 · Cited by 476 · see citing works
Cognitive reactivity to sad mood provocation and the prediction of depressive relapse
Segal, Z. V., Kennedy, S., Gemar, M., Hood, K., Pedersen, R., & Buis, T. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.749 · Cited by 470 · see citing works
Paying the price: the cost of mental health care in England to 2026
McCrone, P., Dhanasiri, S., Patel, A. K., Knapp, M. R. J., & Lawton-Smith, S. H. (2008) · Research Portal (King's College London) · Cited by 439 · see citing works
Segal, Z. V., Gemar, M. C., & Williams, S. (1999) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.108.1.3 · Cited by 356 · see citing works
Segal, Z. V., Gemar, M., & Williams, S. (1999) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.108.1.3 · Cited by 355 · see citing works
The D ysfunctional Att itude Scale: A Validation Study
Weissman, A. (1979) · Scholarly Commons (University of Pennsylvania) · Cited by 330 · see citing works
The pleasant events schedule: Studies on reliability, validity, and scale intercorrelation.
MacPhillamy, D. J., & Lewinsohn, P. M. (1982) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.50.3.363 · Cited by 308 · see citing works
Predictors of Relapse in Major Depressive Disorder
Keller, M. B. (1983) · JAMA · doi:10.1001/jama.1983.03340240025024 · Cited by 304 · see citing works
Bockting, C. L., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.003 · Cited by 295 · see citing works
Kessing, L. V., Hansen, M. G., Andersen, P. K., & Angst, J. (2004) · Acta Psychiatrica Scandinavica · doi:10.1046/j.1600-0447.2003.00266.x · Cited by 258 · see citing works
Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression
Fresco, D. M., Segal, Z. V., Buis, T., & Kennedy, S. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.447 · Cited by 256 · see citing works
Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C., Berking, M., & Andersson, G. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002542 · Cited by 253 · see citing works
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1046 · Cited by 252 · see citing works
Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., Beasley, Jr., Michelson, D., Roback, P., & Sundell, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1247 · Cited by 204 · see citing works
Relapse and recurrence prevention in depression: Current research and future prospects
Beshai, S., Dobson, K. S., Bockting, C. L. H., & Quigley, L. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.09.003 · Cited by 165 · see citing works
Abnormal Electroencephalographic Sleep Profiles in Major Depression
Thase, M. E. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020013003 · Cited by 142 · see citing works
Personality and personality disorders predict development and relapses of major depression
Alnæs, R., & Torgersen, S. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09641.x · Cited by 116 · see citing works
Cognitive and behavioral theories in clinical practice
Kazantzis, N., Reinecke, M. A., & Freeman, A. (2009) · Cited by 112 · see citing works
Brenner, K., Schmitz, N., Pawliuk, N., Fathalli, F., Joober, R., Ciampi, A., & King, S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.017 · Cited by 111 · see citing works
Harkness, K. L., Bagby, R. M., & Kennedy, S. H. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0027665 · Cited by 110 · see citing works
Use of cognitive therapy for relapse prevention in chronic depression
Scott, J. L., Palmer, S., Paykel, E. S., Teasdale, J., & Hayhurst, H. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.182.3.221 · Cited by 109 · see citing works
Antonuccio, D. O., Thomas, M., & Danton, W. G. (1997) · Behavior Therapy · doi:10.1016/s0005-7894(97)80043-3 · Cited by 108 · see citing works
Cognitive therapy in relapse prevention in depression.
Paykel, E. (2007) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006912 · Cited by 99 · see citing works
Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression
Lok, A., Mocking, R. J. T., Ruhé, H. G., Visser, I., Koeter, M. W. J., Assies, J., Bockting, C. L. H., Olff, M., & Schene, A. H. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.10.005 · Cited by 99 · see citing works
Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression
Lok, A., Bockting, C., Koeter, M. W. J., Snieder, H., Assies, J., Mocking, R. J. T., Vinkers, C. H., Kahn, R. S., Boks, M. P., & Schene, A. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.60 · Cited by 63 · see citing works
Predictors of relapse in major depressive disorder
Keller, M. B. (1983) · JAMA · doi:10.1001/jama.250.24.3299 · Cited by 60 · see citing works
Wigman, J. T. W., van Os, J., Abidi, L., Huibers, M. J. H., Roelofs, J., Arntz, A. R., Kelleher, I., & Peeters, F. P. M. L. (2013) · Psychological Medicine · doi:10.1017/s0033291713000871 · Cited by 58 · see citing works
Lethbridge, R., & Allen, N. B. (2008) · Behaviour Research and Therapy · doi:10.1016/j.brat.2008.06.011 · Cited by 54 · see citing works
van Rijsbergen, G. D., Bockting, C., Burger, H., Spinhoven, P., Koeter, M. W. J., Ruhé, H. G., Hollon, S. D., & Schene, A. H. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0032223 · Cited by 54 · see citing works
Harkness, K. L., Theriault, J. E., Stewart, J. G., & Bagby, R. M. (2013) · Depression and Anxiety · doi:10.1002/da.22177 · Cited by 45 · see citing works
Forand, N. R., & DeRubeis, R. J. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0032985 · Cited by 36 · see citing works
Elgersma, H. J., Glashouwer, K. A., Bockting, C., Penninx, B. W. J. H., & de Jong, P. J. (2013) · Journal of Abnormal Psychology · doi:10.1037/a0034933 · Cited by 33 · see citing works
Rucci, P., Frank, E., Calugi, S., Miniati, M., Benvenuti, A., Wallace, M. L., Fagiolini, A. M., Maggi, L., Kupfer, D. J., & Cassano, G. B. (2011) · Depression and Anxiety · doi:10.1002/da.20894 · Cited by 32 · see citing works
Delgadillo, J., Rhodes, L., Moreea, O., McMillan, D., Gilbody, S. M., Leach, C., Lucock, M. P., Lutz, W., & Ali, S. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000485386 · Cited by 28 · see citing works
Self-citationAdvances in Cognitive-Behavioural Therapy for Unipolar Depression
Kuyken, W., Dalgleish, T., & Holden, E. (2007) · Canadian journal of psychiatry. Revue canadienne de psychiatrie · doi:10.1177/070674370705200103 · Cited by 24 · see citing works
Chopra, K. K., Segal, Z. V., Buis, T., Kennedy, S. H., & Levitan, R. D. (2008) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2008.09.006 · Cited by 17 · see citing works
Gollan, J. K., Gortner, E. T., & Dobson, K. S. (2006) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465806002839 · Cited by 16 · see citing works
Quiring, J., Monroe, S. M., Simons, A. D., & Thase, M. E. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00341-x · Cited by 6 · see citing works
Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 7
- Eysenck, 1968, Eysenck Personality Inventory Manual
- 2009, Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Healthcare
- 2000, Practice guideline for the treatment of patients with major depressive disorder (revision), American Journal of Psychiatry, 157, 1
- Möller, 2011, Relapse or recurrence in depression: why has the cutoff been set at 6 months, Medicographia, 33, 125
- Spitzer, 1985, Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders
- National Institute for Health and Care Excellence (NICE) (2010). Depression: The Treatment and Management of Depression in Adults (updated edition). London, UK: The British Psychological Society and The Royal College of Psychiatrists.
- 2000, DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders
Cited by
Sorted by citations
Lam, R. W. M., Kennedy, S. H., Adams, G. C., Bahji, A., Beaulieu, S., Bhat, V., Blier, P., Blumberger, D. M., Brietzke, E. M., Chakrabarty, T., et al. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241245384 · Cited by 408 · see citing works
Delgadillo, J., & Duhne, P. G. S. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000476 · Cited by 101 · see citing works
Self-citationA meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders
Levy, H. C., O’Bryan, E. M., & Tolin, D. F. (2021) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2021.102407 · Cited by 91 · see citing works
Yasin, S., Othmani, A., Raza, I., & Hussain, S. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106741 · Cited by 90 · see citing works
Predicting relapse or recurrence of depression: systematic review of prognostic models
Moriarty, A. S., Meader, N., Snell, K. I. E., Riley, R. D., Paton, L. W., Dawson, S., Hendon, J., Chew-Graham, C. A., Gilbody, S., Churchill, R., et al. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.218 · Cited by 71 · see citing works
Breedvelt, J., Warren, F. C., Segal, Z. V., Kuyken, W., & Bockting, C. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0823 · Cited by 65 · see citing works
Lorimer, B., Kellett, S., Nye, A., & Delgadillo, J. (2021) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2020.1812709 · Cited by 62 · see citing works
Self-citationHehlmann, M. I., Schwartz, B., Lutz, T., Penedo, J. M. G., Rubel, J. A., & Lutz, W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.613085 · Cited by 38 · see citing works
Towards personalized allocation of patients to therapists.
Delgadillo, J., Rubel, J. A., & Barkham, M. (2020) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000507 · Cited by 37 · see citing works
Self-citationLevy, H. C., Stevens, K. T., & Tolin, D. F. (2022) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13486 · Cited by 36 · see citing works
A Computational Theory of Mindfulness Based Cognitive Therapy from the “Bayesian Brain” Perspective
Manjaly, Z., & Iglesias, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00404 · Cited by 35 · see citing works
Prognostic models for predicting relapse or recurrence of major depressive disorder in adults
Moriarty, A. S., Meader, N., Snell, K. I. E., Riley, R. D., Paton, L. W., Chew-Graham, C. A., Gilbody, S. M., Churchill, R. C., Phillips, R. S., Ali, S., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013491.pub2 · Cited by 35 · see citing works
Lokkerbol, J., Wijnen, B. F. M., Ruhé, H. G., Spijker, J., Morad, A., Schoevers, R. A., de Boer, M. K., Cuijpers, P. J., & Smit, F. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1844566 · Cited by 34 · see citing works
Zhou, Y., Zhao, D., Zhu, X., Liu, L., Meng, M., Shao, X., Zhu, X., Xiang, J., He, J., Zhao, Y., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-023-02604-1 · Cited by 35 · see citing works
Gómez Penedo, J. M., Babl, A. M., grosse Holtforth, M., Hohagen, F., Krieger, T., Lutz, W., Meyer, B., Moritz, S., Klein, J. P., & Berger, T. (2020) · Journal of Medical Internet Research · doi:10.2196/15824 · Cited by 33 · see citing works
de Hond, A., van Buchem, M. M., Fanconi, C., Roy, M., Blayney, D. W., Kant, I. M. J., Steyerberg, E. W., & Hernandez‐Boussard, T. (2024) · JMIR Medical Informatics · doi:10.2196/51925 · Cited by 30 · see citing works
Lorimer, B., Delgadillo, J., Kellett, S., & Brown, G. P. (2019) · Psychotherapy Research · doi:10.1080/10503307.2019.1650980 · Cited by 28 · see citing works
Self-citationSmit, A. C., & Snippe, E. (2022) · Psychological Medicine · doi:10.1017/s0033291722002069 · Cited by 27 · see citing works
Altaweel, N., Upthegrove, R., Surtees, A. D. R., Durdurak, B. B., & Marwaha, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1176355 · Cited by 24 · see citing works
Johnco, C. J., Zagic, D., Rapee, R. M., Kangas, M., & Wuthrich, V. M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.033 · Cited by 24 · see citing works
Bolinski, F., Etzelmüller, A., De Witte, N. A. J., van Beurden, C., Debard, G., Bonroy, B., Cuijpers, P., Riper, H., & Kleiboer, A. (2021) · Behaviour Research and Therapy · doi:10.1016/j.brat.2021.103877 · Cited by 23 · see citing works
Atik, E., Schückes, M., & Apolinário-Hagen, J. (2022) · JMIR Mental Health · doi:10.2196/36806 · Cited by 22 · see citing works
Westas, M., Lundgren, J., Andersson, G., Mourad, G., & Johansson, P. (2022) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvab131 · Cited by 22 · see citing works
Li, Y., & Tang, C. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1447207 · Cited by 21 · see citing works
Lawrence, A. J., Stahl, D. R., Duan, S., Fennema, D., Jaeckle, T., Young, A. H., Dazzan, P., Moll, J., & Zahn, R. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.06.010 · Cited by 20 · see citing works
A Lightweight Machine Learning Approach to Detect Depression from Speech Analysis
Verde, L., Raimo, G., Vitale, F., Carbonaro, B., Cordasco, G., Marrone, S., & Esposito, A. A. (2021) · IEEE International Conference on Tools with Artificial Intelligence (ICTAI) · doi:10.1109/ictai52525.2021.00054 · Cited by 20 · see citing works
Whiston, A., Lennon, A., Brown, C., Looney, C., Larkin, E., O'Sullivan, L., Sik, N., & Semkovska, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.746678 · Cited by 19 · see citing works
Palacios, J. E., Enrique, Á., Mooney, O., Farrell, S., Earley, C., Duffy, D. J., Eilert, N., Harty, S., Timulák, L., & Richards, D. (2022) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2743 · Cited by 16 · see citing works
Yang, X., Yang, G., Wang, R., Wang, Y., Zhang, S., Wang, J., Yu, C., & Ren, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1098943 · Cited by 16 · see citing works
Teutenberg, L., Stein, F., Thomas‐Odenthal, F., Usemann, P. L., Brosch, K., Winter, N. R., Goltermann, J., Leenings, R., Konowski, M., Barkhau, C., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.060 · Cited by 16 · see citing works
An interdisciplinary multimodal integrative healthcare program for depressive and anxiety disorders
Wijnen, J., Gordon, N. L., Hullenaar, G. V. ’., Pont, M. L., Geijselaers, M. W. H., Oosterwijck, J. V., & de Jong, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1113356 · Cited by 14 · see citing works
Lindner, P., Dafgård, P., Miloff, A., Andersson, G., Reuterskiöld, L., Hamilton, W., & Carlbring, P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.645273 · Cited by 14 · see citing works
Nieto, I., & Vázquez, C. (2021) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2021.102459 · Cited by 14 · see citing works
Lorimer, B., Delgadillo, J., Kellett, S., & Lawrence, J. (2020) · Psychotherapy Research · doi:10.1080/10503307.2020.1733127 · Cited by 13 · see citing works
Self-citationZhou, J., Zhou, J. L., Feng, Z., Feng, L., Xiao, L., Xu, C., Yang, J., Feng, Y., & Wang, G. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.01.012 · Cited by 12 · see citing works
Collins, A. C., Price, G. D., Woodworth, R. J., & Jacobson, N. C. (2023) · The Journal of Positive Psychology · doi:10.1080/17439760.2023.2254743 · Cited by 11 · see citing works
Between- versus within-person emotional and cognitive reactivity in relation to depressive symptoms
Cole, D. A., Gabruk, M. E., Nestor, B. A., Liu, Q., Lovette, A. J., Zhang, Y., & Mick, C. R. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.064 · Cited by 11 · see citing works
CBT for difficult-to-treat depression: self-regulation model
Barton, S. B., Armstrong, P. V., Robinson, L. J., & Bromley, E. H. C. (2023) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465822000273 · Cited by 10 · see citing works
Banerjee, S., Wu, Y., Bingham, K. S., Marino, P., Meyers, B. S., Mulsant, B. H., Neufeld, N. H., Oliver, L. D., Power, J. D., Rothschild, A. J., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723002945 · Cited by 9 · see citing works
Dikaios, E., Escobar, S., Nassim, M., Su, C., Torres-Platas, S. G., & Rej, S. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5360 · Cited by 9 · see citing works
Hasani, M., Zenoozian, S., Ahmadi, R., Khakpoor, S., Saberi, S., Pirzeh, R., & Saed, O. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07065-y · Cited by 8 · see citing works
Thiruchselvam, T., Patel, A., Daros, A. R., Jain, E., Asadi, S., Laposa, J. M., Kloiber, S. M., & Quilty, L. C. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113446 · Cited by 8 · see citing works
Huang, F., Chen, W., Lin, Y. A., Hong, Y., & Chen, B. (2020) · International Journal of Mental Health Nursing · doi:10.1111/inm.12789 · Cited by 8 · see citing works
Kumagai, N., Tajika, A., Hasegawa, A., Kawanishi, N., Fujita, H., Tsujino, N., Jinnin, R., Uchida, M., Okamoto, Y., Akechi, T., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113919 · Cited by 8 · see citing works
Is perceived control of depression related to therapy outcome for depression? A longitudinal study
Ulleberg, P., Berge, T., Lending, H. D., Skule, C., & Landrø, N. I. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.025 · Cited by 7 · see citing works
Lucock, M. P., Borthwick, R., Cupac, J., Elliott, R., Howell, R., Kendal, S., Khan, W., Sandford, D. M., & Tolley, B. (2021) · Psychotherapy Research · doi:10.1080/10503307.2021.1959079 · Cited by 7 · see citing works
Identifying relapse predictors in individual participant data with decision trees
Böttcher, L., Breedvelt, J., Warren, F. C., Segal, Z. V., Kuyken, W., & Bockting, C. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05214-9 · Cited by 7 · see citing works
Lam, R. W., Rnic, K., Nunez, J.-J., Ho, K., LeMoult, J., Nunes, A., Chakrabarty, T., Foster, J. A., Frey, B. N., Harkness, K. L., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251337603 · Cited by 6 · see citing works
Gathier, A. W., Verhoeven, J. E., van Oppen, P., Penninx, B. W. J. H., Merkx, M. J. M., Dingemanse, P., Stehouwer, K. M. K. S., van den Bulck, C. M. M., & Vinkers, C. H. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04518-0 · Cited by 6 · see citing works
Eckley, D., Allen, A., Millear, P. M. R., Rune, K. T., & Mason, J. (2023) · Cognitive Therapy and Research · doi:10.1007/s10608-023-10403-7 · Cited by 6 · see citing works
Purrington, J., Nye, A., & Beail, N. (2021) · Advances in Mental Health and Intellectual Disabilities · doi:10.1108/amhid-05-2021-0023 · Cited by 6 · see citing works
Flint, A. J., Bingham, K. S., Alexopoulos, G. S., Marino, P., Mulsant, B. H., Neufeld, N. H., Rothschild, A. J., Voineskos, A. N., Whyte, E. M., & Meyers, B. S. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.12.011 · Cited by 6 · see citing works
Vittengl, J. R., Stutzman, S. E., Atluru, A., & Jarrett, R. B. (2019) · Behavior Therapy · doi:10.1016/j.beth.2019.10.008 · Cited by 6 · see citing works
Weijers, A., Rasing, S. P. A., Creemers, D. H. M., Vermulst, A. A., Schellekens, A., & Westerhof, G. J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.048 · Cited by 5 · see citing works
Bockting, C., Breedvelt, J., & Brouwer, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00224-7 · Cited by 5 · see citing works
Moriarty, A. S., Paton, L. W., Snell, K. I. E., Riley, R. D., Buckman, J. E. J., Gilbody, S. M., Chew-Graham, C. A., Ali, S., Pilling, S., Meader, N., et al. (2021) · Diagnostic and Prognostic Research · doi:10.1186/s41512-021-00101-x · Cited by 5 · see citing works
Self-citationNegative mood regulation as a mechanism of change in cognitive therapy for depression.
Areas, M., Penedo, J. M. G., Alalú, N., Babl, A. M., Roussos, A., & grosse Holtforth, M. (2021) · Psychotherapy · doi:10.1037/pst0000373 · Cited by 4 · see citing works
Moriarty, A. S., Paton, L. W., Snell, K. I. E., Archer, L., Riley, R. D., Buckman, J. E. J., Chew-Graham, C. A., Gilbody, S. M., Ali, S., Pilling, S., et al. (2024) · BMJ Mental Health · doi:10.1136/bmjment-2024-301226 · Cited by 4 · see citing works
Self-citationNawaz, S., Bee, P., & Faija, C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.054 · Cited by 4 · see citing works
Clinical outcomes from blended care therapy for anxiety and depression in the year after treatment
Lee, J. L., Chen, S.-Y., Wickham, R. E., Wang, P., Wu, M. S., Varra, A. A., Chen, C., & Lungu, A. (2024) · Internet Interventions · doi:10.1016/j.invent.2024.100798 · Cited by 4 · see citing works
Siyoum, M., Kibrom, E., Fanta, T., Matheyose, E., Adem, K., Dechasa, D. B., Asfaw, H., Darcho, S. D., & Dereje, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087006 · Cited by 4 · see citing works
Wijnen, J., Hullenaar, G. V. ’., Gordon, N. L., Pont, M. L., Geijselaers, M. W. H., Oosterwijck, J. V., & de Jong, J. R. (2022) · Psychotherapy Research · doi:10.1080/10503307.2022.2144528 · Cited by 4 · see citing works
Forster, A., Rodrigues, J., Sperlich, B., & Hewig, J. S. (2026) · Psychophysiology · doi:10.1111/psyp.70217 · Cited by 3 · see citing works
Rojas, R., Behnke, A., & Hautzinger, M. (2021) · Cognitive Therapy and Research · doi:10.1007/s10608-021-10280-y · Cited by 3 · see citing works
Haddad, R. H., Alhusamiah, B. K., Haddad, R. H., Aldaieflih, M. M., Yaseen, K. M., Abuhashish, Y. H., Hamdan‐Mansour, A. M., & Alshraideh, J. A. (2024) · Mental Health and Social Inclusion · doi:10.1108/mhsi-03-2024-0045 · Cited by 3 · see citing works
CBT for difficult-to-treat depression: single complex case
Barton, S. B., Armstrong, P. V., Holland, S., & Tyson-Adams, H. (2022) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x22000319 · Cited by 3 · see citing works
Toward a synthesis of cognitive behaviour therapy via component analysis of self‐regulation
Arco, L. (2023) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2918 · Cited by 3 · see citing works
Walker, N., Vernon-Smith, M., & Townend, M. (2021) · Mental Health Review Journal · doi:10.1108/mhrj-01-2021-0005 · Cited by 3 · see citing works
Abu-Ashour, W., Delaney, S., Farrell, A., Gamble, J., Hawboldt, J., & Sale, J. E. M. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251322401 · Cited by 2 · see citing works
Meyer, J. D., Kelly, S. J. E., Gidley, J. M., Lansing, J. E., Smith, S. L., Churchill, S. L., Connolly, M. L., Thomas, E. B. K., Goldberg, S. B., Abercrombie, H. C., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121606 · Cited by 2 · see citing works
Penedo, J. M. G., Krieger, T., Koditek, M. C., & Holtforth, M. G. (2020) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2020.101576 · Cited by 2 · see citing works
A Computational Theory of Mindfulness Based Cognitive Therapy from the “Bayesian Brain” PerspectivePreprint
Manjaly, Z., & Iglesias, S. (2019) · doi:10.31234/osf.io/qu5gb · Cited by 2 · see citing works
Dyresen, A., Penedo, J. M. G., Babl, A., & Holtforth, M. G. (2025) · Psychotherapy Research · doi:10.1080/10503307.2025.2504465 · Cited by 1 · see citing works
Noda, S., Nakagawa, A., Umeda, S., Amano, M., Nogami, W., Ihara, S., Kobayashi, Y., Ozawa, M., Takemura, R., Uchida, H., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1671393 · Cited by 1 · see citing works
Challenges of Care in Patients with Severe Mental Disorders: An Integrative Review
Saber, S., & Kianian, T. (2023) · Knowledge of Nursing Journal · doi:10.61186/knjournal.1.3.238 · Cited by 1 · see citing works
Manshadi, Z. D., Doost, H. T. N., Jobson, L., & Raes, F. (2025) · European Journal of Psychotraumatology · doi:10.1080/20008066.2025.2514328 · Cited by 1 · see citing works
Associations among subthreshold depression, cognitive bias, and mentalization in university students
Zeng, Y., Liu, B., Yu, H., Jia, Y., Chen, H., Zheng, P., & Qian, H. (2025) · BMC Public Health · doi:10.1186/s12889-025-25930-z · Cited by 1 · see citing works
von Stackelberg, P., Goedhart, R., Huberts, L. C. E., Lokkerbol, J., & Birbil, Ş. İ. (2025) · Quality and Reliability Engineering International · doi:10.1002/qre.70139 · Cited by 1 · see citing works
Milligan, T., Nair, R., Cowansage, K. K., Boyd, C. C., Morgan, M. A., Kotzab, D., Bellanti, D. M., Shank, L. M., Berman, D. E., Chari, S. A., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121377 · Cited by 1 · see citing works
Dönnhoff, I., Kindermann, D., Stahl-Toyota, S., Nowak, J. A., Orth, M., Friederich, H.-C., & Nikendei, C. (2026) · Psychotherapy Research · doi:10.1080/10503307.2026.2621740 · Cited by 1 · see citing works
Cludius, B., & Ehring, T. W. (2023) · CBT: science into practice · doi:10.1007/978-3-031-23650-1_2 · Cited by 1 · see citing works
Saulnier, K. G., Panaite, V., Ganoczy, D. A., Kim, H. M., Zivin, K., Hofer, T. P., Piette, J. D., & Pfeiffer, P. N. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.10.008 · Cited by 1 · see citing works
Chauvin, G. V., Hoyt, D. L., & Otto, M. W. (2022) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2022.04.003 · Cited by 1 · see citing works
French, J., Brown, R. J., & Bell, T. (2023) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2304041 · Cited by 1 · see citing works
Puder, L. M., Winter, N. R., Goltermann, J., Meinert, S. L., Flinkenflügel, K., Krieger, J., Hubbert, J. M., Leenings, R., Fisch, L., Ernsting, J., et al. (2025) · medRxiv · doi:10.1101/2025.10.22.25334871 · Cited by 1 · see citing works
Tekrarlama Krizi ve Psikoterapi Etkililik Çalışmaları
Türkarslan, K. K. (2022) · Psikoloji Çalışmaları / Studies in Psychology · doi:10.26650/sp2021-959170
Ganjoori, M., Golshani, F., Baghdasarians, A., & Vahed, E. (2023) · Complementary Medicine Journal · doi:10.61186/cmja.13.1.20
Dehn, L. B., Beckendorf, B., Michel, J., Drießen, M., & Beblo, T. (2024) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026/1616-3443/a000769
Coutts‐Bain, D., Sharpe, L., & Hunt, C. J. (2025) · British Journal of Clinical Psychology · doi:10.1111/bjc.12536
Tatnell, R., Constanti, A., Johansen, S. W. F., & Demmer, D. H. (2025) · Australian Psychologist · doi:10.1080/00050067.2025.2484001
de Filippis, R., & Foysal, A. A. (2025) · OALib · doi:10.4236/oalib.1113197
Mapping Emotional Memories in Depression: An Exploratory Analysis
Stemerding, L., Beurs, D. P. D., Arntz, A. R., & Kindt, M. (2025) · Cognitive Therapy and Research · doi:10.1007/s10608-025-10617-x
Walter, K. H., Otis, N. P., Crocker, L. D., Myers, H. C., Elliott, K. T. K., & Michalewicz-Kragh, B. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1638576
Cognitive behavioural therapy for seasonal affective disorder: a systematic review and meta-analysis
Melton, S., Wieland, S., Bastounis, A., & Carter, T. (2025) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x2510024x
Heim, P., Brose, A., Böttche, M., Peters, E. M. J., Ehrenthal, J. C., Knaevelsrud, C., & Kerber, A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-106741
Gathier, A. W., Verhoeven, J., van Oppen, P., Penninx, B. W. J. H., Merkx, M. J. M., Dingemanse, P., Stehouwer, K. M. K. S., van den Bulck, C. M. M., & Vinkers, C. H. (2023) · Figshare · doi:10.6084/m9.figshare.22599298
Böttcher, L., Breedvelt, J., Warren, F. C., Segal, Z. V., Kuyken, W., & Bockting, C. (2023) · Figshare · doi:10.6084/m9.figshare.24558116
Plattonen, A., Mylläri, S., Saarni, S. E., & Rosenström, T. H. (2026) · British Journal of Clinical Psychology · doi:10.1111/bjc.70036
Wb, Z., Zhang, H., Shi, G., Chen, R., Yiming, S., Wang, W., Guo, L., Liu, Y., Liao, Y., Hao, J., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.121116
Kalde, J., Atik, E., Stricker, J., Schückes, M., Neudeck, P., Abel, P., Hollank, J., Pittig, A., & Pietrowsky, R. (2026) · Psychotherapy and Psychosomatics · doi:10.1159/000550820
- Authors
- Wojnarowski, C., Firth, N., Finegan, M., & Delgadillo, J.
- Affiliations
- University of Sheffield (GB)
- Corresponding author
- Wojnarowski, Caroline
- Venue
- Behavioural and Cognitive Psychotherapy
- Publisher
- Cambridge University Press (CUP)
- Published
- 2019-03-21
- Volume
- 47
- Issue
- 5
- Pages
- 514-529
- ISSN
- 1352-4658 (ISSN-L)
- 1469-1833
- OpenAlex
- W2906420156
- Semantic Scholar
- 1e09ba2efd15d1e8d6e17722669310f81e5613bc
- Cited by
- 108
- References
- 69
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 11 · 2023: 20 · 2022: 12 · 2021: 22 · 2020: 10 · 2019: 4
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural and Cognitive Psychotherapy (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- cognitive behavioral therapy, major depressive disorder, depression relapse, depression recurrence, predictors of relapse, residual depressive symptoms, cognitive reactivity, life events, personality factors
- MeSH terms
- Depression, Major Depressive Disorder, Humans, Prognosis, Recurrence, Risk Factors, Cognitive Behavioral Therapy, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review